Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medical vs Surgical Treatment of BPH in NMIBC Patients
NCT02443844Phase 4Unknown
- Sponsor
- Dışkapı Yıldırım Beyazıt Training and Research Hospital
- Start
- Feb 2015
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tamsulosin in benign prostatic hyperplasia (BPH) (2 arms), sponsored by Dışkapı Yıldırım Beyazıt Training and Research Hospital. Primary endpoint: Tumour Recurrence at 3 years. Status: unknown.
02
Drugs
tamsulosin
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT02443844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02443844.